SecBot SecBot
144 ·Filed Nov 16, 2026

CBLL

Ceribell, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed1d 9h ago SEC0001959173-26-008019
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small relative to market cap and insider holdings, and is filed by a director, not the CEO or CFO. Monitor for actual sale completion on Form 4; this filing alone does not signal a material change in insider sentiment.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$26.42
T+0 close · Nov 16, 2026 · via day close
Latest settled
−1.70%
T+1 · $25.97
Vs SPY
−0.69%
α at T+1
Next horizon
T+5
in 5d
  1. T+0 · Nov 16 $26.42entry
  2. T+1 · 13h ago −1.70%α −0.69% · $25.97
  3. T+5 · in 5d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Josef Parvizi filed a Form 144 notice of intent to sell 25,000 shares of Ceribell, Inc. (CBLL), valued at approximately $652,250. The shares were acquired pre-IPO in 2014 and are held in a trust account of which Parvizi is a trustee and stakeholder. This is a relatively small sale relative to the company's $1.0B market cap and the insider's total holdings, and the filing is an advance notice of intent, not a completed transaction.

Key Facts

  • Director Josef Parvizi filed Form 144 to sell 25,000 shares of Ceribell, Inc.
  • Estimated aggregate value of the proposed sale is $652,250.
  • Shares were acquired pre-IPO on 08/29/2014 via cash purchase from the issuer.
  • The sale is proposed to occur on or about 11/16/2026 on NASDAQ.
  • The shares are held in the Innovation Acp Trust account, of which Parvizi is a trustee and stakeholder.
  • The filing is an advance notice of intent; the sale may not occur.

Financial Impact

Proposed sale of 25,000 shares valued at ~$652,250, representing approximately 0.065% of the company's $1.0B market cap.

dilution

Risk Factors

  • The sale is an advance notice and may not be completed; no actual insider selling has occurred yet.
  • Director-level sales carry less signal than C-suite sales.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-008019
Document: 0001959173-26-008019-index.html0001959173-26-008019
Document: 0001959173-26-008019.txt0001959173-26-008019

Track record

39 reports on CBLL

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+1. Best: +17.06% at T+60 after the Feb 23, 2026 report. 8 of 10 went positive at some point.

Filters
  1. Nov 17, 2026today Insider Cluster Neutral 3/10 Entry $26.09 Now $26.42 +1.26% settles Nov 19
  2. Nov 16, 20261d ago SC 13G/A Neutral 2/10 Entry $26.42 Now $26.42 +0.00% settles Nov 18
  3. Nov 16, 20261d ago 144 Neutral 2/10 Viewing Entry $26.42 to $25.97 Now $26.42 +0.00% ▼ −1.70% −0.69% vs SPY
  4. Nov 13, 20264d ago Insider Cluster Neutral 2/10 Entry $26.42 to $25.97 Now $26.42 +0.00% ▼ −1.70% −0.69% vs SPY
  5. Nov 12, 20265d ago 144 Neutral 2/10 Entry $26.14 to $26.42 Now $26.42 +1.07% ▲ +1.07% +2.98% vs SPY
  6. Nov 10, 20267d ago Insider Cluster Neutral 2/10 Entry $27.80 to $26.35 Now $26.42 −4.96% ▼ −5.22% −4.86% vs SPY
  7. Nov 9, 20268d ago 144 Neutral 2/10 Entry $27.60 to $27.48 Now $26.42 −4.28% ▼ −0.43% −0.07% vs SPY
  8. Nov 3, 202614d ago 8-K Neutral 5/10 No price data
  9. Nov 3, 202614d ago Press Release Neutral 5/10 Entry $27.39 to $26.01 Now $26.42 −3.54% ▼ −5.04% −0.63% vs SPY
  10. Nov 2, 202615d ago 144 Neutral 2/10 Entry $26.96 to $28.27 Now $26.42 −2.00% ▲ +4.86% +4.56% vs SPY
Showing 10 of 39

US Market Status

Market Closed · Opens Thu (13h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026